Yıl: 2018 Cilt: 5 Sayı: 1 Sayfa Aralığı: 41 - 46 Metin Dili: İngilizce DOI: 10.14744/nci.2017.50480 İndeks Tarihi: 07-10-2020

Evaluation of Patients with Gastric Polyps

Öz:
OBJECTIVE: The incidence of gastric polyps (GPs) greatly differs according to study populations and was found to be 0.33%–6.7% in various studies. The majority of GPs are composed of hyperplastic polyps (HPs), fundic gland polyps (FGPs), and adenomatous polyps (APs). Although APs have a high risk of malignant potential, sporadic FGPs have no malignant potential. Conversely, HPs have a low risk of malignant potential. It is not sufficient to perform a biopsy to identify the polyp type and the presence of dysplasia; thus, some polyps may require multiple biopsies or total excision.METHODS: This retrospective study included patients with GPs or polypoid lesions found on esophagogastroscopy with polyp or malignant histology on biopsy at Ankara Numune Training and Research Hospital Endoscopy Unit between 2005 and 2011.RESULTS: In a series of 56.300 upper endoscopies, 192 patients (0.34%) were found to have GPs. Among the patients, 51 (26.6%) were men and 151 (73.4%) were women. The average age of the patients was 61.9±13.3 (14–90) years. The frequency of HPs, APs, and FGPs were 88%, 2.6%, and 1.6%, respectively. The size of the polyps was ≤1 cm in 137 (70%) patients. One polyp was determined in 141 (73.4%) patients. The most common localizations of polyps were the antrum and corpus. Endoscopic snare polypectomy was performed in 64 patients. One bleeding episode was observed, which required endoscopic treatment after ESP.CONCLUSION: In our study, the GP frequency was low (0.34%), whereas the frequency of HP maybe high due to the high frequency of Helicobacter pylori (HPy) infection in our country. The frequency of FGP is probably low due to the high frequency of HPy infection and the short-term use of proton-pump inhibitors.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B; British Society of Gastroenterology. The management of gastric polyps. Gut 2010;59:1270–6.
  • Oberhuber G, Stolte M. Gastric polyps: an update of their pathology and biological significance. Virchows Arch 2000;437:581–90.
  • Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009;104:1524–32.
  • Morais DJ, Yamanaka A, Zeitune JM, Andreollo NA. Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol 2007;44:14–7.
  • Makar GA, Ginsberg GG. Gastric Polyps. In: Faigel DO, Kochman ML, editors. Endoscopic Oncology. New Jersey: Humana Press; 2006. p. 109–20.
  • Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N. Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients. World J Gastroenterol 2003;9:2236–9.
  • Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006;24:1341–8.
  • García-Alonso FJ, Martín-Mateos RM, González Martín JA, Foruny JR, Vázquez-Sequeiros E, Boixeda de Miquel D. Gastric polyps: analysis of endoscopic and histological features in our center. Rev Esp Enferm Dig 2011;103:416–20.
  • Elhanafi S, Saadi M, Lou W, Mallawaarachchi I, Dwivedi A, Zuckerman M, et al. Gastric polyps: Association with Helicobacter pylori status and the pathology of the surrounding mucosa, a cross sectional study. World J Gastrointest Endosc 2015;7:995–1002.
  • Macenlle García R, Bassante Flores LA, Fernández Seara J. Gastric epithelial polyps. A retrospective study 1995-2000. Rev Clin Esp 2003;203:368–72.
  • Roseau G, Ducreux M, Molas G, Ponsot P, Amouyal P, Palazzo L, et al. Epithelial gastric polyps in a series of 13000 gastroscopies. Presse Med 1990;19:650–4.
  • Fan NN, Yang J, Sun G, Lu ZS, Ling Hu EQ, Wang XD, et al. Changes in the spectrum of gastric polyps in the Chinese population. World J Gastroenterol 2015;21:9758–64.
  • Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the ¹³C-Urea breath test. BMC Public Health 2013;13:1215.
  • Molaei M, Mashayekhi R, Zojaji H, Haghazali M, Zali MR. Gastric polypoid lesions: analysis of histopathologic features of 107 endoscopic polypectomy specimens. Gastroenterology and Hepatology From Bed to Bench 2008;1:127–32.
  • Karaman A, Deniz K, Karaman H, Gürsoy Ş, Başkol M, Güven K, et al. Prevalence and histopathological condition of gastric polyps in Central Anatolia. Endoskopi Dergisi 2011;2:56–8.
  • Buyukasik K, Sevinc MM, Gunduz UR, Ari A, Gurbulak B, Toros AB, et al. Upper gastrointestinal tract polyps: what do we know about them? Asian Pac J Cancer Prev 2015;16:2999–3001.
  • Vatansever S, Akpınar Z, Alper E, İpek S, Yazıcıoğlu N, Ekinci N, et al. Gastric polyps and polypoid lesions: Retrospective analysis of 36650 endoscopic procedures in 29940 patients. Turk J Gastroenterol 2015;26:117–22.
  • Demiryilmaz I, Albayrak Y, Yilmaz SP. Frequency of various types of gastric polyp. Cumhuriyet Med J 2011;33:209–14.
  • Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust 1992;157:287–8.
  • Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy 1994;26:659 65.
  • el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 1997;92:1858–60.
  • Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 2001;116:716–20.
  • Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol 1998;110:615–21.
  • Hongo M, Fujimoto K; Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol 2010;45:618–24.
  • Yamamoto A, Ishiguro H, Kondo T, Naruse S, Goto H. Low prevalence of Helicobacter pylori infection in patients with fundic gland polyps. Nihon Rinsho 2005;63 Suppl 11:621–4.
  • Turner JR, Odze RD. Polyps of the Stomach. In: Odze R, Goldblum J. Surgical pathology of GI tract, Liver, Bilary tract and Pancreas. Saunders-Elsevier; p. 415–44.
  • Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 1995;27:32–7.
  • Park DI, Rhee PL, Kim JE, Hyun JG, Kim YH, Son HJ, et al. Risk factors suggesting malignant transformation of gastric adenoma: univariate and multivariate analysis. Endoscopy 2001;33:501–6.
  • Nam KW, Song KS, Lee HY, Lee BS, Seong JK, Kim SH, et al. Spectrum of final pathological diagnosis of gastric adenoma after endoscopic resection. World J Gastroenterol 2011;17:5177–83.
  • Matsushita M, Hajiro K, Okazaki K, Takakuwa H. Endoscopic features of gastric inflammatory fibroid polyps. Am J Gastroenterol 1996;91:1595–8.
APA ÖLMEZ Ş, sayar s, Sarıtaş B, SAVAŞ A, AVCIOĞLU U, Tenlik İ, Ozaslan E, KÖSEOĞLU H, Altiparmak E (2018). Evaluation of Patients with Gastric Polyps. , 41 - 46. 10.14744/nci.2017.50480
Chicago ÖLMEZ Şehmus,sayar süleyman,Sarıtaş Bünyamin,SAVAŞ Ayla Yıldız,AVCIOĞLU Ufuk,Tenlik İlyas,Ozaslan Ersan,KÖSEOĞLU Hasan Tankut,Altiparmak Emin Evaluation of Patients with Gastric Polyps. (2018): 41 - 46. 10.14744/nci.2017.50480
MLA ÖLMEZ Şehmus,sayar süleyman,Sarıtaş Bünyamin,SAVAŞ Ayla Yıldız,AVCIOĞLU Ufuk,Tenlik İlyas,Ozaslan Ersan,KÖSEOĞLU Hasan Tankut,Altiparmak Emin Evaluation of Patients with Gastric Polyps. , 2018, ss.41 - 46. 10.14744/nci.2017.50480
AMA ÖLMEZ Ş,sayar s,Sarıtaş B,SAVAŞ A,AVCIOĞLU U,Tenlik İ,Ozaslan E,KÖSEOĞLU H,Altiparmak E Evaluation of Patients with Gastric Polyps. . 2018; 41 - 46. 10.14744/nci.2017.50480
Vancouver ÖLMEZ Ş,sayar s,Sarıtaş B,SAVAŞ A,AVCIOĞLU U,Tenlik İ,Ozaslan E,KÖSEOĞLU H,Altiparmak E Evaluation of Patients with Gastric Polyps. . 2018; 41 - 46. 10.14744/nci.2017.50480
IEEE ÖLMEZ Ş,sayar s,Sarıtaş B,SAVAŞ A,AVCIOĞLU U,Tenlik İ,Ozaslan E,KÖSEOĞLU H,Altiparmak E "Evaluation of Patients with Gastric Polyps." , ss.41 - 46, 2018. 10.14744/nci.2017.50480
ISNAD ÖLMEZ, Şehmus vd. "Evaluation of Patients with Gastric Polyps". (2018), 41-46. https://doi.org/10.14744/nci.2017.50480
APA ÖLMEZ Ş, sayar s, Sarıtaş B, SAVAŞ A, AVCIOĞLU U, Tenlik İ, Ozaslan E, KÖSEOĞLU H, Altiparmak E (2018). Evaluation of Patients with Gastric Polyps. İstanbul Kuzey Klinikleri, 5(1), 41 - 46. 10.14744/nci.2017.50480
Chicago ÖLMEZ Şehmus,sayar süleyman,Sarıtaş Bünyamin,SAVAŞ Ayla Yıldız,AVCIOĞLU Ufuk,Tenlik İlyas,Ozaslan Ersan,KÖSEOĞLU Hasan Tankut,Altiparmak Emin Evaluation of Patients with Gastric Polyps. İstanbul Kuzey Klinikleri 5, no.1 (2018): 41 - 46. 10.14744/nci.2017.50480
MLA ÖLMEZ Şehmus,sayar süleyman,Sarıtaş Bünyamin,SAVAŞ Ayla Yıldız,AVCIOĞLU Ufuk,Tenlik İlyas,Ozaslan Ersan,KÖSEOĞLU Hasan Tankut,Altiparmak Emin Evaluation of Patients with Gastric Polyps. İstanbul Kuzey Klinikleri, vol.5, no.1, 2018, ss.41 - 46. 10.14744/nci.2017.50480
AMA ÖLMEZ Ş,sayar s,Sarıtaş B,SAVAŞ A,AVCIOĞLU U,Tenlik İ,Ozaslan E,KÖSEOĞLU H,Altiparmak E Evaluation of Patients with Gastric Polyps. İstanbul Kuzey Klinikleri. 2018; 5(1): 41 - 46. 10.14744/nci.2017.50480
Vancouver ÖLMEZ Ş,sayar s,Sarıtaş B,SAVAŞ A,AVCIOĞLU U,Tenlik İ,Ozaslan E,KÖSEOĞLU H,Altiparmak E Evaluation of Patients with Gastric Polyps. İstanbul Kuzey Klinikleri. 2018; 5(1): 41 - 46. 10.14744/nci.2017.50480
IEEE ÖLMEZ Ş,sayar s,Sarıtaş B,SAVAŞ A,AVCIOĞLU U,Tenlik İ,Ozaslan E,KÖSEOĞLU H,Altiparmak E "Evaluation of Patients with Gastric Polyps." İstanbul Kuzey Klinikleri, 5, ss.41 - 46, 2018. 10.14744/nci.2017.50480
ISNAD ÖLMEZ, Şehmus vd. "Evaluation of Patients with Gastric Polyps". İstanbul Kuzey Klinikleri 5/1 (2018), 41-46. https://doi.org/10.14744/nci.2017.50480